Who is sponsoring NCT04529343?

NCT04529343 is sponsored by Istanbul University.

What drugs are being tested in NCT04529343?

Interventions in NCT04529343: Virtual reality mediated upper extremity rehabilitation, Classical exercise therapy for upper extremities.

What condition does NCT04529343 study?

NCT04529343 studies Cerebral Palsy, Upper Extremity Paresis.

Is NCT04529343 still recruiting?

NCT04529343 is currently completed. Last updated 20 March 2023.

Last reviewed 2023-03-20 · How we verify

NCT04529343

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Virtual Reality Mediated Upper Extremity rehabilitationPatients With Cerebral Palsy

Completed NA Last updated 20 March 2023

What this trial tests

NA trial testing Virtual reality mediated upper extremity rehabilitation in Cerebral Palsy in 40 participants. Completed in 30 December 2020.

Timeline

20 August 2020

Primary endpoint
30 December 2020

30 December 2020

Quick facts

Lead sponsor	Istanbul University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	40
Start date	20 August 2020
Primary completion	30 December 2020
Estimated completion	30 December 2020
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

Virtual reality mediated upper extremity rehabilitation
Classical exercise therapy for upper extremities

Conditions studied

Cerebral Palsy — all drugs for Cerebral Palsy →
Upper Extremity Paresis — all drugs for Upper Extremity Paresis →

Sponsor

Istanbul University

Who can join

Adults 5 to 12, any sex, with Cerebral Palsy or Upper Extremity Paresis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Cerebral palsy (CP) refers to a group of permanent disorders that occur in the brain of the fetus or infant, which are non-progressive, cause movement and posture disorder along with activity limitation. The upper extremity is frequently affected in patients with CP. The prevalence of upper extremity involvement has been reported between 60-83% in different studies. Virtual reality applications have been increasing recently in the field of neurological rehabilitation. In this study, researchers aimed to investigate the effectiveness of virtual reality-mediated upper extremity rehabilitation in patients with hemiplegic cerebral palsy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Cerebral Palsy

Currently open trials in the same condition.

NCT07524972 — Antenatal Magnesium Sulphate in High-Risk Preterm Patients · Phase 3 · recruiting
NCT07432789 — Metrological Properties of a Digital Motion Analysis Research Application for Assessing the Motor Abilities and Performa · NA · recruiting
NCT07466914 — Constipation in Children With Cerebral Palsy · active not recruiting
NCT05901259 — The EXOPULSE Study - a Database for Routine Follow-up of Clinical Outcomes · recruiting
NCT07342348 — Using Power Mobility Training to Promote Arm & Hand Function in Children With Cerebral Palsy · NA · recruiting

Other Istanbul University trials

Trials by the same sponsor.

NCT07472946 — Whole-Body Vibration Exercise in Patients With Parkinson's Disease · NA · not yet recruiting
NCT07433894 — Scoliosis and Functional Outcomes in Children With Juvenile Idiopathic Arthritis · not yet recruiting
NCT07420049 — Turkish Adaptation of the CTS-6 Evaluation Tool: A Validation and Reliability Study · not yet recruiting
NCT07415967 — The Effect of a Dual-Task Technique-Based Exercise Program on Clinical Outcomes in Rotator Cuff Related Shoulder Pain · NA · recruiting
NCT07473024 — pEEG-Guided Anesthesia and Behavioral Outcomes in Children · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04529343 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Istanbul University
Last refreshed: 20 March 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04529343.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing